Best Bang For Your Buck? 2 Bargain Stocks with 30%+ Upside

Core Insights - The article discusses investment opportunities in undervalued companies with growth potential, specifically highlighting DexCom Inc. and The Trade Desk Inc. as attractive options for investors [1][2]. DexCom Inc. (NASDAQ: DXCM) - DexCom is a leader in diabetes monitoring systems, with a market capitalization of approximately $30 billion and a significant share in the global continuous glucose monitoring market [3][4]. - The company has experienced a slight decline in share price over the past year, attributed to a slowdown in annual revenue growth; however, it reported a 15% year-over-year organic revenue growth in Q2 and raised its full-year guidance [4][5]. - DexCom's P/E ratio stands at 52.78, which is lower than the healthcare sector average of 75.38, indicating a potential buying opportunity as it is near its lowest P/E ratio in five years [6]. - Analysts project a 31% upside potential for DexCom's stock, estimating a price target of just under $100 per share [6]. The Trade Desk Inc. (NASDAQ: TTD) - The Trade Desk has faced challenges, including a significant drop in share price (61% YTD) following a mixed earnings report, where sales exceeded expectations but earnings fell short [7][10]. - The company has seen decelerating revenue growth due to competition from Meta Platforms, which has leveraged its AI technology to gain an advantage in the advertising space [8]. - Despite current challenges, The Trade Desk's Kokai platform is showing growth, capturing 75% of client spend last quarter, suggesting potential for future revenue increases [9]. - Analysts see a 36% upside potential for The Trade Desk, although opinions are mixed on whether now is the right time to invest, with a P/E ratio of 54.51 being the lowest in years [11].